Literature DB >> 5297294

Experimental anticancer studies. XXXI. On the streptococcal preparation having potent anticancer activity.

H Okamoto, M Minami, S Shoin, S Koshimura, R Shimizu.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5297294

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN： 0021-5031


× No keyword cloud information.
  21 in total

1.  Sclerotherapy of cervical cysts with Picibanil (OK-432).

Authors:  Stephan Knipping; Gerrit Goetze; Kerstin Neumann; Marc Bloching
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-03       Impact factor: 2.503

2.  Successful OK-432 therapy for a supraclavicular lymphocele: report of a case.

Authors:  Simon Florian Preuss; Claus Wittekindt; Dirk Beutner; Karl-Bernd Huttenbrink
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-15       Impact factor: 2.503

Review 3.  [Sclerotherapy for cystic lesions of the head and neck region].

Authors:  S Knipping; G Goetze
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

4.  Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy.

Authors:  S Yamasaki; T Okino; N Kan; K Satoh; K Mise; Y Teramura; T Harada; H Kodama; T Hori; K Ohgaki
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Unique genomic arrangements in an invasive serotype M23 strain of Streptococcus pyogenes identify genes that induce hypervirulence.

Authors:  Yunjuan Bao; Zhong Liang; Claire Booyjzsen; Jeffrey A Mayfield; Yang Li; Shaun W Lee; Victoria A Ploplis; Hui Song; Francis J Castellino
Journal:  J Bacteriol       Date:  2014-09-15       Impact factor: 3.490

6.  Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients.

Authors:  S Fujimoto; M Takahashi; T Minami; H Ishigami; M Miyazaki; K Itoh
Journal:  Jpn J Surg       Date:  1979-09

7.  Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy.

Authors:  S Yamasaki; N Kan; T Harada; Y Ichinose; Y Moriguchi; L Li; T Sugie; H Kodama; K Satoh; K Ohgaki
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Enhanced hydrogen peroxide release from macrophages stimulated with streptococcal preparation OK-432.

Authors:  H Saito; H Tomioka
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

9.  CovRS-Regulated Transcriptome Analysis of a Hypervirulent M23 Strain of Group A Streptococcus pyogenes Provides New Insights into Virulence Determinants.

Authors:  Yun-Juan Bao; Zhong Liang; Jeffrey A Mayfield; Shaun W Lee; Victoria A Ploplis; Francis J Castellino
Journal:  J Bacteriol       Date:  2015-07-27       Impact factor: 3.490

10.  [Sclerotherapy with OK-432 for cystic tumors in the neck region].

Authors:  M Bloching; G Götze; M Passmann; K Neumann
Journal:  HNO       Date:  2005-03       Impact factor: 1.284
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.